Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18669454rdf:typepubmed:Citationlld:pubmed
pubmed-article:18669454lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0034380lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0346647lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0671970lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0814225lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:18669454lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:18669454pubmed:issue22lld:pubmed
pubmed-article:18669454pubmed:dateCreated2008-8-1lld:pubmed
pubmed-article:18669454pubmed:abstractTextTo compare clinical benefit response (CBR) and quality of life (QOL) in patients receiving gemcitabine (Gem) plus capecitabine (Cap) versus single-agent Gem for advanced/metastatic pancreatic cancer.lld:pubmed
pubmed-article:18669454pubmed:languageenglld:pubmed
pubmed-article:18669454pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18669454pubmed:citationSubsetIMlld:pubmed
pubmed-article:18669454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18669454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18669454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18669454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18669454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18669454pubmed:statusMEDLINElld:pubmed
pubmed-article:18669454pubmed:monthAuglld:pubmed
pubmed-article:18669454pubmed:issn1527-7755lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:ScheithauerWe...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:KornekGabriel...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:HerrmannRicha...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:KöhneClaus-He...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:GlimeliusBeng...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:BajettaEmilio...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:PestalozziBer...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:DietrichDanie...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:SalettiPierca...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:FigerArieAlld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:StemmerSalomo...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:BernhardJürgJlld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:SchüllerJohan...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:BauerJeanJlld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:MingroneWalte...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:BodokyGyörgyGlld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:KoeberleDiete...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:RuhstallerTho...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:TàmasKarinKlld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:Central...lld:pubmed
pubmed-article:18669454pubmed:authorpubmed-author:GerberDaniela...lld:pubmed
pubmed-article:18669454pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18669454pubmed:day1lld:pubmed
pubmed-article:18669454pubmed:volume26lld:pubmed
pubmed-article:18669454pubmed:ownerNLMlld:pubmed
pubmed-article:18669454pubmed:authorsCompleteYlld:pubmed
pubmed-article:18669454pubmed:pagination3695-701lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:meshHeadingpubmed-meshheading:18669454...lld:pubmed
pubmed-article:18669454pubmed:year2008lld:pubmed
pubmed-article:18669454pubmed:articleTitleClinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.lld:pubmed
pubmed-article:18669454pubmed:affiliationSwiss Group for Clinical Cancer Research Coordinating Center, Bern, Switzerland. juerg.bernhard@ibcsg.orglld:pubmed
pubmed-article:18669454pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18669454pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18669454pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18669454pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18669454pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:18669454pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18669454lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18669454lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18669454lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18669454lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18669454lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18669454lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18669454lld:pubmed